Fortis Group Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.9K Hold
250
﹤0.01% 328
2026
Q1
$18K Hold
250
﹤0.01% 351
2025
Q4
$19.8K Hold
250
﹤0.01% 346
2025
Q3
$18.8K Hold
250
﹤0.01% 301
2025
Q2
$17.2K Hold
250
﹤0.01% 298
2025
Q1
$16.9K Hold
250
﹤0.01% 265
2024
Q4
$11.2K Hold
250
﹤0.01% 299
2024
Q3
$15.7K Hold
250
﹤0.01% 266
2024
Q2
$14.8K Hold
250
﹤0.01% 262
2024
Q1
$19.9K Sell
250
-250
-50% -$19.1K ﹤0.01% 261
2023
Q4
$39.5K Buy
500
+250
+100% +$17.8K 0.01% 182
2023
Q3
$17.5K Buy
+250
New +$17.7K 0.01% 184
2020
Q3
$14K Buy
+250
New +$15.6K ﹤0.01% 263

Other funds holding CVS

Fortis Group Advisors's CVS Position: Q2 2026 in Review

Fortis Group Advisors held its CVS Health (CVS) position steady in Q2 2026 at 250 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #328.

Fortis Group Advisors first reported a position in CVS in Q3 2020 and has held it in 13 quarters since. The position peaked at $39.5K in Q4 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Fortis Group Advisors held 250 shares of CVS Health worth $25.9K as of Q2 2026.
  • Fortis Group Advisors left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up ﹤0.01% of Fortis Group Advisors's portfolio in Q2 2026, its #328 holding.
  • Fortis Group Advisors first reported a position in CVS Health in Q3 2020 and has held it in 13 quarters since.
  • Fortis Group Advisors's CVS Health position peaked at $39.5K in Q4 2023.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.